loader from loading.io
How AI is supporting pharmaceutical manufacturing and supply chain show art How AI is supporting pharmaceutical manufacturing and supply chain

EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O’Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.

info_outline
How the path to a sustainable health system unlocks value show art How the path to a sustainable health system unlocks value

EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry.   Our panel of experts discuss the evolution of sustainability in health. The explore where organizations can start on their sustainability journey, how they can create sustainable change, and reduce climate impact. Through exploring global examples. they show how data and analytics play a key role in long-term strategies and regulatory compliance. Join in and discover the steps to lessen...

info_outline
How global events are shaping the pharmaceutical supply chain show art How global events are shaping the pharmaceutical supply chain

EY Health Sciences & Wellness podcast series

In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry.   The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unfolding around us. The discussion covers the impact of global events that have led to a revaluation of globalized supply chain models and a creation of a new, optimised model where the end-to-end visibility is a crucial factor. Join us as we...

info_outline
How life sciences companies are measuring their ESG impact show art How life sciences companies are measuring their ESG impact

EY Health Sciences & Wellness podcast series

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact.   Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the information flow that helps businesses successfully engage with their stakeholders.   The conversation also explores global use cases, the significance of banking for impact, and the gaps in impact...

info_outline
How unlocking the power of data can fuel better health outcomes show art How unlocking the power of data can fuel better health outcomes

EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation and look into innovation in healthcare and health care data science.   They discuss the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that needs ever more healthcare. But alongside the complexities, there are opportunities for disruptive...

info_outline
How women are shaping the life sciences industry show art How women are shaping the life sciences industry

EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis.   Together they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those critical lessons they have learned from their mentors and supporters along the way. They offer valuable...

info_outline
How data can help redesign the health experience show art How data can help redesign the health experience

EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS, discuss the importance of data science in healthcare and how it can help redesign the health experience and the future of health.   In this wide-ranging discussion, the expert panel approach the topic of health economy and smart health from their different perspectives. Whether you’re a doctor or researcher, a programmer or a CIO, whether you work...

info_outline
How shorter clinical trial processes prolong the lives of patients show art How shorter clinical trial processes prolong the lives of patients

EY Health Sciences & Wellness podcast series

There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy.   In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss the...

info_outline
How digital solutions will help close the health equity gap show art How digital solutions will help close the health equity gap

EY Health Sciences & Wellness podcast series

In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for finding opportunities to provide health equity and discuss the root causes of disparities and how unbiased digital medicine can help.   We learn that health care disparity starts much earlier than diagnosis and treatment, with low minority enrolment rates in clinical trials leading to results that don't reflect the population. The COVID-19 pandemic has...

info_outline
The Age of Health Experience show art The Age of Health Experience

EY Health Sciences & Wellness podcast series

In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience” and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic.   The Covid 19 impact on healthcare was immense and Health Sciences and Wellness industry has never been as “front and centre” in our lives as it has been in this last year. As all of us, worldwide, ride the various waves of the pandemic, our Health Sciences and Wellness industry has taken the lead in healthcare analytics and healthcare...

info_outline
 
More Episodes

In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O’Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.